Skip to main content
UniHealth

Doctor search

Ramani K Chaganti, MD

Rheumatology · Berkeley

NPI 1306045695

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
2 carriers
Offices
5
Since medical school
27 years
Temple University School of Medicine, 1999

Offices

5 locations · UCSF Medical Group Business Services · University of California San Francisco · Regents of the University of California

Looking this up.

Hospitals listed: Marinhealth Medical Center · UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

12 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chaganti’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

12 of 12 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Marinhealth Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Marinhealth Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.66 (3.59 to 7.73) · 1,505 casesWorseJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.177BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.85 (0 to 1.83) · 1,056 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.04 (0.72 to 1.36)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths167.34 (112.58 to 222.09) · 57 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 47 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.5 · 119 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.6 · 257 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 428 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.4 · 477 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.3 · 197 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.1 · 2,827 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.38) · 6,990 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.41) · 6,838 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.41 (0 to 3) · 664 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.86 (1.4 to 4.33) · 1,436 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths10.38 (3.68 to 17.08) · 705 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.38 (0.72 to 8.04) · 672 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.66 (0.18 to 3.15) · 300 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.56 (0 to 1.25) · 5,550 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.4 · 76 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.396No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 275 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits22 · 427 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-20.3 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits3.3 · 494 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-4.9 · 499 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17.9 · 435 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.5 (3.6 to 8.4) · 93 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits11.2 (7.8 to 16) · 93 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6.6 · 84 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 111 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (10.3 to 16.5) · 2,119 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.1 (0.8 to 1.4) · 670 casesNo differentJan 2024 – Dec 2024

What patients said (1,233 patients answered, 19% of those asked)

Patient survey stars by topic at Marinhealth Medical Center
Cleanliness3
Nurse communication3
Doctor communication3
Communication about medicines2
Discharge information3
Overall hospital rating4
Quietness3
Recommend hospital4
Share of patients giving the best answer at Marinhealth Medical Center
Room was "always" clean68%
Nurses "always" communicated well73%
Doctors "always" communicated well74%
Staff "always" explained56%
Yes, staff "did" give patients this information85%
Yes, staff "did" give patients information about help after discharge85%
Doctors "always" explained things so they could understand71%
Doctors "always" listened carefully72%
Doctors "always" treated them with courtesy and respect80%
Patients who gave a rating of "9" or "10" (high)72%
Staff "always" explained new medications70%
Nurses "always" explained things so they could understand68%
Nurses "always" listened carefully68%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night48%
"YES", patients would definitely recommend the hospital76%
Staff "always" explained possible side effects43%
Yes, staff "did" give patients information about possible symptoms85%
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$32,318

Medicare paid this office $32,318 for 133 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)52$13,941$119
Return visit (30+ min)72$10,437$80
Return visit (30+ min)18$2,433$81
Long return visit (40+ min)15$1,820$91
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's14$207$15

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Aspiration and/or injection of fluid from large joint22–15–––

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

133 Original Medicare patients in 2024. Average age 71 · Women 80% · Also on Medicaid 31% · Health risk score 1.72. Above the middle of the specialty; the typical rheumatology clinician is at 1.38.

Conditions among them: High blood pressure 65% · Depression 23% · Coronary heart disease 20% · Chronic kidney disease 20% · Diabetes 19% · Heart failure 17% · Atrial fibrillation 17% · Cancer 16% · COPD 13%.

The office billed $221,174, Medicare allowed $44,252 and paid $32,318; for 376 services of 16 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024133376711.72$221,174$32,318
2023136337721.69$210,395$31,654
2022150401721.45$242,260$33,778
2021195421701.51$243,685$34,365
2020218435711.66$259,902$29,553
2019235546711.70$344,663$39,623
2018258562701.66$340,496$39,504
2017240504711.64$300,798$38,756
2016201462681.73$268,680$35,098
2015194445681.57$265,119$35,999
2014168393671.37$234,346$30,923
2013134266681.41$136,327$18,703

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Original Medicare services billed in 2023
Long return visit (40+ min)51$11,867$122
Return visit (30+ min)61$8,909$80
Return visit (30+ min)27$3,363$84
Long return visit (40+ min)18$3,248$120

2022: 4 services

Original Medicare services billed in 2022
Return visit (30+ min)91$12,852$75
Long return visit (40+ min)54$12,443$119
Return visit (30+ min)31$3,828$72
Long return visit (40+ min)11$1,433$119

2021: 6 services

Original Medicare services billed in 2021
Return visit (30+ min)105$13,717$81
Long return visit (40+ min)47$8,090$114
Return visit (30+ min)28$3,081$79
Long return visit (40+ min)14$1,642$109
Telephone medical discussion with physician, 11-20 minutes12$668$51
Aspiration and/or injection of fluid from large joint11$635$42

2020: 6 services

Original Medicare services billed in 2020
Return visit (30+ min)107$10,204$61
Long return visit (40+ min)48$8,082$89
Long return visit (40+ min)28$2,820$85
Return visit (30+ min)30$2,208$61
Short return visit (20+ min)34$1,581$44
Short return visit (20+ min)13$601$46

2019: 5 services

Original Medicare services billed in 2019
Return visit (30+ min)122$13,199$63
Long return visit (40+ min)69$12,253$88
Long return visit (40+ min)40$4,716$96
Return visit (30+ min)36$3,355$62
Aspiration and/or injection of fluid from large joint15$884$40

2018: 6 services

Original Medicare services billed in 2018
Return visit (30+ min)120$12,593$61
Long return visit (40+ min)88$12,059$82
Long return visit (40+ min)52$5,878$93
Return visit (30+ min)43$3,673$62
New patient visit (45+ min)11$1,141$104
Aspiration and/or injection of fluid from large joint12$920$40

2017: 6 services

Original Medicare services billed in 2017
Long return visit (40+ min)74$12,489$92
Return visit (30+ min)95$9,368$62
Long return visit (40+ min)45$5,268$98
Return visit (30+ min)40$3,779$65
New patient visit (45+ min)33$3,385$103
Aspiration and/or injection of fluid from large joint14$898$39

2016: 6 services

Original Medicare services billed in 2016
Return visit (30+ min)98$10,935$61
Long return visit (40+ min)49$8,948$89
New patient visit (45+ min)32$3,615$113
Return visit (30+ min)36$3,489$66
Long return visit (40+ min)18$2,294$96
Aspiration and/or injection of fluid from large joint13$942$39

2015: 5 services

Original Medicare services billed in 2015
Long return visit (40+ min)77$13,155$91
Return visit (30+ min)112$12,832$67
New patient visit (45+ min)25$2,876$115
New patient visit (60+ min)16$2,417$151
Aspiration and/or injection of fluid from large joint12$777$43

2014: 5 services

Original Medicare services billed in 2014
Return visit (30+ min)103$12,452$65
Long return visit (40+ min)73$9,891$89
New patient visit (60+ min)26$3,893$150
New patient visit (45+ min)14$1,627$116
Aspiration and/or injection of fluid from large joint13$903$41

2013: 5 services

Original Medicare services billed in 2013
Return visit (30+ min)85$7,798$60
Long return visit (40+ min)23$3,068$96
New patient visit (60+ min)18$2,622$146
New patient visit (45+ min)16$1,821$114
Short return visit (20+ min)22$887$35

Medicaid work

$1,203 in 2020

Medicaid paid $1,203 for 35 billed services this clinician did in 2020, up to 17 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2020
Return visit (30+ min)35$1,203
Medicaid work by year
202035117$1,203
201912112$736
201815115$617
See the largest Medicaid services in earlier years

2019

Largest Medicaid services in 2019
Return visit (30+ min)12$736

2018

Largest Medicaid services in 2018
Return visit (30+ min)15$617

Drugs they prescribed that Part D paid

$906,228

Pharmacies billed $906,228 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 7% of their Part D prescriptions (64 of 862) in 2024. Above the middle of the specialty; the typical rheumatology clinician is at 3%.

698 generic and fewer than 11 brand-name prescriptions · $906,228 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Humira(Cf)16$160,255$10,016
Enbrel Mini20$144,695$7,235
Xeljanz20$113,017$5,651
Rasuvo17$11,593$682
Leflunomide35$1,925$55
See all 24 drugs
Every Part D drug this clinician prescribed
Humira(Cf)16$160,255$10,016
Enbrel Mini20$144,695$7,235
Xeljanz20$113,017$5,651
Rasuvo17$11,593$682
Leflunomide35$1,925$55
Lidocaine13$1,753$135
Hydroxychloroquine Sulfate34$1,734$51
Methotrexate89$1,510$17
Colchicine22$1,499$68
Prednisone130$1,341$10
Hydrocodone-Acetaminophen43$1,018$24
Celecoxib27$788$29
Diclofenac49$720$15
Cyclobenzaprine23$534$23
Etodolac17$381$22
Alendronate20$322$16
Omeprazole13$265$20
Gabapentin26$251$10
Allopurinol13$241$19
Methotrexate16$193$12
Ibuprofen14$92$7
Meloxicam19$69$4
Tramadol14$39$3
Sulfasalazine11$17$2

Year by year

Part D prescribing by year
20248621017% (64)None$906,228
20239581097% (69)None$1,091,641
20229231289% (83)None$782,729
20211,0111577% (67)None$935,794
202088915510% (85)None$525,155
20191,0381716% (64)16%$493,568
20181,2111704% (44)22%$664,806
20171,1121523% (37)21%$619,062
20161,1501345% (60)17%$421,516
20159081265% (46)26%$342,539
20148331135% (42)None$182,391
20136941023% (19)23%$85,677

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 26 drugs

Part D drugs prescribed in 2023
Humira(Cf)32$392,175$12,255
Enbrel Mini19$129,957$6,840
Humira11$82,972$7,543
Benlysta11$57,321$5,211
Enbrel11$40,393$3,672
Rasuvo15$8,817$588
Methotrexate103$3,690$36
Hydroxychloroquine Sulfate51$2,988$59
Prednisone153$2,764$18
Leflunomide38$2,165$57
Lidocaine11$1,824$166
Diclofenac59$1,396$24
Sulfasalazine Dr27$1,367$51
Hydrocodone-Acetaminophen35$992$28
Celecoxib22$969$44
Colchicine15$967$64
Cyclobenzaprine21$630$30
Etodolac12$465$39
Alendronate41$463$11
Acetaminophen-Codeine16$271$17
Methotrexate19$254$13
Meloxicam19$245$13
Gabapentin15$216$14
Tramadol14$161$11
Ibuprofen14$156$11
Sulfamethoxazole-Trimethoprim14$72$5

2022: 22 drugs

Part D drugs prescribed in 2022
Humira(Cf)26$255,729$9,836
Enbrel Mini18$113,999$6,333
Orencia Clickject13$70,507$5,424
Benlysta11$50,036$4,549
Mitigare17$5,953$350
Clobetasol Propionate13$4,695$361
Leflunomide30$4,013$134
Methotrexate96$3,687$38
Colchicine14$2,513$180
Hydroxychloroquine Sulfate56$2,504$45
Prednisone166$2,118$13
Diclofenac64$1,269$20
Lidocaine14$1,269$91
Etodolac15$666$44
Hydrocodone-Acetaminophen32$490$15
Cyclobenzaprine20$482$24
Alendronate48$378$8
Methotrexate22$359$16
Gabapentin17$263$15
Tramadol33$234$7
Metoprolol11$113$10
Meloxicam16$62$4

2021: 20 drugs

Part D drugs prescribed in 2021
Humira(Cf)18$192,376$10,688
Enbrel Sureclick17$115,713$6,807
Orencia Clickject15$103,756$6,917
Tymlos17$37,361$2,198
Leflunomide27$3,864$143
Methotrexate109$3,691$34
Hydroxychloroquine Sulfate53$3,600$68
Colchicine15$3,042$203
Clobetasol Propionate11$2,885$262
Prednisone163$2,749$17
Diclofenac60$1,411$24
Alendronate104$1,127$11
Celecoxib11$939$85
Hydrocodone-Acetaminophen34$830$24
Etodolac17$545$32
Tramadol25$379$15
Allopurinol21$379$18
Methotrexate25$356$14
Cyclobenzaprine15$242$16
Sulfamethoxazole-Trimethoprim12$124$10

2020: 18 drugs

Part D drugs prescribed in 2020
Enbrel Sureclick19$106,195$5,589
Orencia12$57,621$4,802
Leflunomide28$5,682$203
Colcrys14$4,956$354
Hydroxychloroquine Sulfate39$3,852$99
Methotrexate64$3,289$51
Prednisone155$2,666$17
Celecoxib27$1,365$51
Diclofenac47$1,195$25
Hydrocodone-Acetaminophen35$944$27
Alendronate81$868$11
Azathioprine11$697$63
Tramadol38$534$14
Sulfasalazine Dr12$422$35
Methotrexate19$339$18
Allopurinol17$225$13
Meloxicam21$135$6
Cyclobenzaprine13$117$9

2019: 22 drugs

Part D drugs prescribed in 2019
Xeljanz28$129,844$4,637
Orencia11$48,674$4,425
Benlysta12$46,052$3,838
Methotrexate112$6,418$57
Hydroxychloroquine Sulfate57$5,972$105
Colcrys17$3,682$217
Leflunomide11$3,635$330
Prednisone182$2,895$16
Celecoxib32$2,351$73
Ibandronate16$1,698$106
Alendronate134$1,384$10
Azathioprine13$1,331$102
Diclofenac50$1,278$26
Salsalate11$1,006$91
Hydrocodone-Acetaminophen31$910$29
Methotrexate17$331$19
Allopurinol12$302$25
Tramadol18$240$13
Gabapentin23$187$8
Acyclovir11$147$13
Meloxicam14$105$7
Pantoprazole12$101$8

2018: 26 drugs

Part D drugs prescribed in 2018
Enbrel Sureclick27$162,624$6,023
Xeljanz28$117,260$4,188
Orencia24$87,180$3,632
Forteo12$38,392$3,199
Benlysta11$38,093$3,463
Simponi11$32,824$2,984
Methotrexate128$8,410$66
Hydroxychloroquine Sulfate64$7,080$111
Leflunomide18$4,769$265
Colcrys23$4,716$205
Celecoxib27$3,445$128
Ibandronate50$3,335$67
Colchicine11$2,457$223
Prednisone178$2,092$12
Voltaren21$1,600$76
Azathioprine27$1,112$41
Diclofenac42$949$23
Alendronate137$942$7
Salsalate11$926$84
Sulfasalazine Dr11$574$52
Hydrocodone-Acetaminophen28$539$19
Methotrexate35$509$15
Allopurinol17$502$30
Gabapentin28$298$11
Acyclovir15$257$17
Pantoprazole23$197$9

2017: 27 drugs

Part D drugs prescribed in 2017
Humira31$135,291$4,364
Enbrel Sureclick18$80,016$4,445
Xeljanz19$71,657$3,771
Cimzia13$47,689$3,668
Hydroxychloroquine Sulfate65$10,413$160
Leflunomide29$6,276$216
Methotrexate101$6,252$62
Colcrys21$4,328$206
Colchicine16$4,017$251
Celecoxib19$3,536$186
Prednisone175$2,618$15
Voltaren20$1,569$78
Sulfasalazine Dr18$1,217$68
Ibandronate17$999$59
Allopurinol53$914$17
Diclofenac33$860$26
Etodolac17$843$50
Alendronate146$738$5
Azathioprine23$726$32
Salsalate11$504$46
Gabapentin15$281$19
Hydrocodone-Acetaminophen19$268$14
Acyclovir13$193$15
Omeprazole27$167$6
Methotrexate15$150$10
Pantoprazole17$133$8
Tramadol12$65$5

2016: 27 drugs

Part D drugs prescribed in 2016
Enbrel31$124,737$4,024
Humira18$109,914$6,106
Hydroxychloroquine Sulfate82$14,744$180
Flector12$5,003$417
Methotrexate109$4,695$43
Leflunomide13$3,737$287
Prednisone221$3,730$17
Colchicine16$2,871$179
Voltaren27$1,962$73
Azathioprine36$1,135$32
Sulfasalazine Dr24$987$41
Allopurinol54$945$17
Hydrocodone-Acetaminophen26$914$35
Diclofenac28$708$25
Alendronate116$563$5
Tramadol20$558$28
Sulfasalazine19$449$24
Salsalate12$445$37
Gabapentin23$426$19
Pantoprazole21$302$14
Methotrexate15$284$19
Etodolac11$276$25
Omeprazole23$170$7
Acetaminophen-Codeine12$144$12
Ibuprofen11$127$12
Sulfamethoxazole-Trimethoprim11$52$5
Meloxicam14$45$3

2015: 20 drugs

Part D drugs prescribed in 2015
Enbrel48$155,095$3,231
Hydroxychloroquine Sulfate76$12,070$159
Methotrexate99$5,731$58
Prednisone165$3,009$18
Colcrys17$2,991$176
Celecoxib16$2,986$187
Voltaren56$2,829$51
Leflunomide12$1,849$154
Mycophenolate Mofetil13$1,668$128
Colchicine11$1,559$142
Sulfasalazine Dr15$780$52
Allopurinol42$568$14
Hydrocodone-Acetaminophen22$567$26
Sulfasalazine20$448$22
Azathioprine11$289$26
Gabapentin25$236$9
Omeprazole24$220$9
Alendronate42$204$5
Acetaminophen-Codeine13$121$9
Meloxicam20$98$5

2014: 19 drugs

Part D drugs prescribed in 2014
Humira17$58,428$3,437
Enbrel19$52,424$2,759
Methotrexate95$7,306$77
Celebrex21$5,804$276
Colcrys32$5,715$179
Flector12$4,285$357
Prednisone172$3,546$21
Mycophenolate Mofetil22$3,476$158
Hydroxychloroquine Sulfate62$2,489$40
Voltaren51$2,243$44
Hydrocodone-Acetaminophen26$612$24
Sulfasalazine Dr12$526$44
Sulfasalazine14$382$27
Allopurinol45$243$5
Omeprazole22$222$10
Alendronate24$189$8
Gabapentin16$155$10
Acetaminophen-Codeine13$151$12
Sulfamethoxazole-Trimethoprim22$89$4

2013: 18 drugs

Part D drugs prescribed in 2013
Enbrel11$25,906$2,355
Mycophenolate Mofetil29$5,332$184
Methotrexate79$4,937$62
Colcrys31$4,811$155
Aciphex11$3,491$317
Lidoderm12$3,084$257
Prednisone188$2,671$14
Voltaren30$1,280$43
Hydroxychloroquine Sulfate48$739$15
Omeprazole19$526$28
Sulfasalazine19$410$22
Allopurinol33$250$8
Alendronate13$210$16
Hydrocodone-Acetaminophen13$107$8
Ibuprofen12$68$6
Cyclobenzaprine11$53$5
Sulfamethoxazole-Trimethoprim11$45$4
Folic Acid12$25$2

Money from drug and device companies

$95 in 2025

Industry payments by year
202511None$95
202212None$53
202113None$77

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Janssen BiotechTremfya$95
1 payment
  • Education for Tremfya · 2025-06-11 · $95
See the published payment
Every published payment
Janssen BiotechEducation · 2025-06-11Tremfya$95
See earlier years (2022, 2021)

2022: $53

Payments by company in 2022
AmgenEnbrel$53
2 payments
  • Meals for Enbrel · 2022-02-17 · $27
  • Meals for Enbrel · 2022-01-26 · $27

2021: $77

Payments by company in 2021
AmgenEnbrel$77
3 payments
  • Meals for Enbrel · 2021-12-15 · $26
  • Meals for Enbrel · 2021-12-03 · $29
  • Meals for Enbrel · 2021-11-12 · $21

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
74.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1306045695
Licence
NY 228376
Trained
Temple University School of Medicine, 1999 · 27 years ago
Group
UCSF Medical Group Business Services · University of California San Francisco · Regents of the University of California
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RR0500X (207RR0500X)
Mailing address
360 Forest Ave, Apt 202, Palo Alto, CA, 94301
NPI first listed
2007-07-16
NPI last updated
2007-07-16

This is when the NPI record was last certified, not a medical board exam.